FIELD: medicine.
SUBSTANCE: invention refers to pharmaceutical compound to improve renal function that contains KW-3902 30 mg or its pharmaceutically acceptable salt, ester, amide, and furosemide. Also there are disclosed method to induce diuretic effect, method to improve renal function, method to support renal function and method to recover renal function in a patient.
EFFECT: effective recovery of renal function in patients with congestive heart failure.
13 cl, 2 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HERBAL REMEDY WITH DIURETIC AND NATRIURETIC ACTIVITY FOR THE PREVENTION AND TREATMENT OF DISEASES OF THE URINARY SYSTEM | 2022 |
|
RU2791782C1 |
| COMPOSITION WITH DESAMINO-ARGININE VASOTOCIN FOR PARENTERAL INTRODUCTION AND METHOD FOR ITS PRODUCTION | 2016 |
|
RU2634272C1 |
| PHARMACEUTICAL COMPOSITIONS, INCLUDING NEP INHIBITORS, INHIBITORS OF SYSTEM PRODUCING ENDOGENIC ENDOTHELIUM AND DIURETICS | 2006 |
|
RU2409366C2 |
| USE OF PINOSTROBIN AS DIURETIC AND CREATINURETIC AGENT | 2023 |
|
RU2816948C1 |
| USE OF PINOCEMBRIN AS DIURETIC AND CREATININURETIC AGENT | 2023 |
|
RU2822937C1 |
| DIURETIC | 2009 |
|
RU2408367C1 |
| USE OF OREGANOL A WITH DIURETIC ACTIVITY | 2022 |
|
RU2802873C1 |
| USE OF PATULITRIN AS A DIURETIC | 2022 |
|
RU2807938C1 |
| USE OF QUERCETIN AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802833C1 |
| USE OF DIHYDROQUERCETIN AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802874C1 |
